Health Affairs

Health Affairs, 28, no. 4 (2009): w730-w742 (Published online 30 June 2009) doi: 10.1377/hlthaff.28.4.w730 © 2009 by Project HOPE	New Online   Getting Health Reform Done   After the State of the Union   Incremental Reform   E-Health in Developing World   Most-Read Articles in 2009

This Article Figures Only Full Text (HTML) Reprint (PDF) Appendices Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Laxminarayan, R. Articles by Adeyi, O. Search for Related Content PubMed PubMed Citation Articles by Laxminarayan, R. Articles by Adeyi, O. Related Collections Health Promotion/Disease Prevention AIDS/HIV International Issues Legal/Regulatory Issues Public Health Health Spending Consumer Issues Vaccines

Web Exclusives

Global Investments In TB Control: Economic Benefits

Ramanan Laxminarayan, Eili Y. Klein, Sarah Darley and Olusoji Adeyi

The Global Plan to Stop TB calls for significant financial resources to meet the Millennium Development Goals for tuberculosis. However, it is unclear whether the economic benefits of TB control exceed the costs. Using an epidemiological model, we find that the economic benefits of the Global Plan relative to sustained DOTS (a commonly used treatment method) were unambiguously greater than the incremental costs in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Benefit-cost ratios of sustaining DOTS at current levels relative to having no DOTS exceeded 1 in all twenty-two high-burden, TB-endemic countries and sub-Saharan Africa.

                      What's this?